India upholds patent for Roche's Pegasys
This article was originally published in Scrip
Executive Summary
India has upheld the patent on Roche's Pegasys (pegylated interferon alfa-2a), a treatment for hepatitis C. The patent, which was initially granted in 2006 in India, had been challenged by Wockhardt and Sankalp Rehabilitation Trust, a community-based non-profit organisation.